Vice President Clinical R&D
F2G
Manchester, England, United Kingdom
Daniela Zinzi, MD, Infectious Diseases Specialist
email: dzinzi@f2g.com
LinkedIn Profile: https://www.linkedin.com/in/daniela-zinzi-95171637/
Background
8+ years R&D
10+ years Medical Affairs
15+ years Hospital experience
Current roles
Vice President, Clinical R&D, F2G Ltd.
External Expert Evaluator for the European Commission
Selected as infectious Diseases and Vaccines Expert by the European Medicines Agency (EMA)
REVIVE Contributing Expert (https://revive.gardp.org/daniela-zinzi/)
Senior Advisor - HealthTech180
Researcher Expert on COVID -19 for the Knowledge Exchange Unit, UK Parliament
Certficated by the London School of Hygiene & Tropical Medicine and UK Public
Health Rapid Support (COVID-19: tackling the novel coronavirus)
Former Medical Consultant at GARDP for the Severe Bacterial Infections program.
National Coordinator (Italy) for BEAM Alliance
Disclosure(s): VP Clinical R&D at F2G: Stocks/Bonds (Private Company)
320 - Assessment of Body Weight upon PK of Olorofim in Patients with Invasive Mould Infections
Friday, October 18, 2024
12:35 PM – 12:40 PM US PT